Cetuximab (Erbitux)


Categories: ,



ERBITUX® (cetuximab) is a recombinant, human/mouse chimeric monoclonal antibody that binds specifically to the extracellular domain of the human epidermal growth factor receptor (EGFR).

Cetuximab is composed of the Fv regions of a murine anti-EGFR antibody with human IgG1 heavy and kappa light chain constant regions and has an approximate molecular weight of 152 kDa.

Cetuximab is produced in mammalian (murine myeloma) cell culture. ERBITUX is a sterile, clear, colorless liquid of pH 7.0 to 7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates.

ERBITUX is supplied at a concentration of 2 mg/mL in either 100 mg (50 mL) or 200 mg (100 mL), single-use vials. Cetuximab is formulated in a solution with no preservatives, which contains 8.48 mg/mL sodium chloride, 1.88 mg/mL sodium phosphate dibasic heptahydrate, 0.41 mg/mL sodium phosphate monobasic monohydrate, and Water for Injection, USP.


There are no reviews yet.

Be the first to review “Cetuximab (Erbitux)”

Your email address will not be published. Required fields are marked *


Subscribe To Our Newsletter

Abonnieren Sie unseren Newsletter und erhalten Sie wöchentlich 30% Rabatt auf unsere 

You have Successfully Subscribed!